UY40854A - Péptidos cíclicos dirigidos a fap y conjugados de los mismos - Google Patents

Péptidos cíclicos dirigidos a fap y conjugados de los mismos

Info

Publication number
UY40854A
UY40854A UY0001040854A UY40854A UY40854A UY 40854 A UY40854 A UY 40854A UY 0001040854 A UY0001040854 A UY 0001040854A UY 40854 A UY40854 A UY 40854A UY 40854 A UY40854 A UY 40854A
Authority
UY
Uruguay
Prior art keywords
fap
cyclic peptides
conjugates
peptides directed
imaging
Prior art date
Application number
UY0001040854A
Other languages
English (en)
Inventor
Andrei Alexandrovich Golosov
Salvatore Bongarzore
Davide Camporese
Gonçalo Dos Santos Clemente
Takeru Ehara
Matteo Fischer
Philipp Grosche
Philipp Holzer
Alexei Karpov
Marion Lacaud-Baumlin
Lukas Leder
Rafael Bermeo Malo
Andreas Marzinzik
Yoshihide Mizukoshi
Charlie Munsch
Markus Oliver Reschke
Holger Sellner
Therese-Marie Stachyra
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of UY40854A publication Critical patent/UY40854A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Se describen en la presente péptidos cíclicos dirigidos a la proteína de activación de fibroblastos (FAP) y su incorporación en compuestos para la obtención de imágenes y terapias con radioligandos, así como métodos y/o usos de dichos compuestos para la obtención de imágenes, el tratamiento y/o la prevención de enfermedades y trastornos relacionados con la FAP.
UY0001040854A 2023-08-15 2024-08-13 Péptidos cíclicos dirigidos a fap y conjugados de los mismos UY40854A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363519599P 2023-08-15 2023-08-15
US202463650139P 2024-05-21 2024-05-21

Publications (1)

Publication Number Publication Date
UY40854A true UY40854A (es) 2025-02-28

Family

ID=92712397

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001040854A UY40854A (es) 2023-08-15 2024-08-13 Péptidos cíclicos dirigidos a fap y conjugados de los mismos

Country Status (15)

Country Link
US (1) US20250090699A1 (es)
EP (1) EP4762073A1 (es)
KR (1) KR20260054703A (es)
CN (1) CN121712789A (es)
AU (1) AU2024326078A1 (es)
CL (1) CL2026000382A1 (es)
CO (1) CO2026001441A2 (es)
CR (1) CR20260054A (es)
DO (1) DOP2026000032A (es)
IL (1) IL326227A (es)
MX (1) MX2026001771A (es)
PE (1) PE20260794A1 (es)
TW (1) TW202508616A (es)
UY (1) UY40854A (es)
WO (1) WO2025037249A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026046340A1 (zh) * 2024-08-30 2026-03-05 江苏恒瑞医药股份有限公司 一种f-18标记反应前体分子的方法
WO2026163110A1 (en) * 2025-01-30 2026-08-06 Novartis Ag Combinations with fap targeting compounds and conjugates thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2733117C (en) * 2008-08-08 2016-03-22 Polyphor Ag Template-fixed peptidomimetics
PH12020551205A1 (en) 2018-02-06 2021-04-19 Univ Heidelberg Fap inhibitors
CN116888138A (zh) * 2020-11-30 2023-10-13 瑞择生物公司 放射性药物缀合组合物及其用途

Also Published As

Publication number Publication date
CL2026000382A1 (es) 2026-05-04
WO2025037249A1 (en) 2025-02-20
CN121712789A (zh) 2026-03-20
AU2024326078A1 (en) 2026-02-19
US20250090699A1 (en) 2025-03-20
KR20260054703A (ko) 2026-04-22
IL326227A (en) 2026-03-01
PE20260794A1 (es) 2026-04-08
TW202508616A (zh) 2025-03-01
CR20260054A (es) 2026-03-24
MX2026001771A (es) 2026-04-01
CO2026001441A2 (es) 2026-02-23
DOP2026000032A (es) 2026-03-15
EP4762073A1 (en) 2026-06-24